Our Innovation
Our Innovation
Our device semi-automates the FNA procedure, meeting the six core criteria: increased cellularity, minimal invasiveness, reusability, user-friendliness, cost-effectiveness, and deskilling potential.
Reliable and accurate diagnosis will become accessible to all those in need.
Cellularity Comparison:Â Current Standard vs AutoAspira
Quantification of Cellularity using the AutoAspira Prototype